Literature DB >> 21802892

Community-associated methicillin-resistant Staphylococcus aureus infection in Portugal.

R Nazareth1, J Gonçalves-Pereira, A Tavares, M Miragaia, H de Lencastre, J Silvestre, P Freitas, E Gonçalves, F Martins, V Mendes, C Tapadinhas, P Póvoa.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has recently emerged as a cause of community-acquired infections among individuals without risk factors. Community-associated MRSA (CA-MRSA) appears to be more virulent, causing superficial mild skin and soft tissue infections to severe necrotizing fasciitis, and in rare cases, pneumonia. Community-associated MRSA was first reported in Australia in the early 80s, after almost two decades in the USA, and then in several countries in Europe, Asia and South America. No data exists in Portugal. We report the first case of CA-MRSA infection in Portugal, in a young adult with severe necrotizing pneumonia, complicated with bilateral empyema and respiratory failure.
Copyright © 2011 Sociedade Portuguesa de Pneumologia. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21802892     DOI: 10.1016/j.rppneu.2011.05.007

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  9 in total

Review 1.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

2.  High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries.

Authors:  A Tavares; M Miragaia; J Rolo; C Coelho; H de Lencastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-21       Impact factor: 3.267

Review 3.  Self-disinfecting surfaces and infection control.

Authors:  Micaela Machado Querido; Lívia Aguiar; Paula Neves; Cristiana Costa Pereira; João Paulo Teixeira
Journal:  Colloids Surf B Biointerfaces       Date:  2019-02-16       Impact factor: 5.268

4.  Extensive dissemination of methicillin-resistant Staphylococcus aureus (MRSA) between the hospital and the community in a country with a high prevalence of nosocomial MRSA.

Authors:  Diana Espadinha; Nuno A Faria; Maria Miragaia; Luís Marques Lito; José Melo-Cristino; Hermínia de Lencastre
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

5.  Community-Associated Methicillin-Resistant Staphylococcus aureus Lacking PVL, as a Cause of Severe Invasive Infection Treated with Linezolid.

Authors:  Catarina Gouveia; Alexandra Gavino; Ons Bouchami; Maria Miragaia; Luis Varandas; Herminia de Lencastre; Maria Joao Brito
Journal:  Case Rep Pediatr       Date:  2013-02-20

6.  Contamination of public buses with MRSA in Lisbon, Portugal: a possible transmission route of major MRSA clones within the community.

Authors:  Teresa Conceição; Fernanda Diamantino; Céline Coelho; Hermínia de Lencastre; Marta Aires-de-Sousa
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

7.  [Duration of breastfeeding in preterm infants followed at a secondary referral service].

Authors:  Brunnella Alcantara Chagas de Freitas; Luciana Moreira Lima; Carla Fernanda Lisboa Valente Carlos; Silvia Eloiza Priore; Sylvia do Carmo Castro Franceschini
Journal:  Rev Paul Pediatr       Date:  2015-11-11

8.  Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci.

Authors:  Carla Mottola; Teresa Semedo-Lemsaddek; João J Mendes; José Melo-Cristino; Luís Tavares; Patrícia Cavaco-Silva; Manuela Oliveira
Journal:  J Biomed Sci       Date:  2016-03-08       Impact factor: 8.410

9.  Detection of diverse genotypes of Methicillin-resistant Staphylococcus aureus from hospital personnel and the environment in Armenia.

Authors:  Hermine V Mkrtchyan; Zhen Xu; Maria Yacoub; Mary M Ter-Stepanyan; Hayk D Karapetyan; Angela M Kearns; Ronald R Cutler; Bruno Pichon; Armen Dz Hambardzumyan
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-07       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.